… to eradicate remaining Barrett’s epithelium. Although endoscopic therapy cannot address …
of patients with intramucosal adenocarcinoma in Barrett esophagus and therefore is useful in …

… to a BE expert center for surveillance and/or treatment. BE expert centers should meet the …
endoscopic treatment for HGD or early carcinoma per BE expert endoscopist; endoscopic and …

… SSIM and neoplasia have been reported at variable rates (0% to 30%) and with different
endoscopic therapies. The issue of intestinal metaplasia and neoplasia below the …

… The only known precursor to OAC is Barrett's oesophagus (BO). The overall risk of BO to
progression to OAC is estimated at 0.12%–0.48% per year, while the risk for progression to …

… early detection and treatment of dysplasia to prevent further progression to invasive EAC.
Developments in endoscopic therapy have resulted in a major shift in the treatment of patients …

… , and strides to eliminate post surveillance endoscopy after endoscopic eradication therapy
are essential to reach our long-term goal for eradication of esophageal adenocarcinoma. …

… endoscopy with complete endoscopic clearance of BO or from residual BO after the maximum
number of endoscopic treatment … all oesophageal biopsies obtained at the first endoscopy …

… LGD in Barrett's oesophagus and on the safety and efficacy of endoscopic treatment in
this … were downgraded to non-dysplastic Barrett's oesophagus or indefinite for dysplasia (IND). …

… Endoscopic eradication therapy (EET) has significantly changed the management of patients
with BE-related neoplasia and allows a minimally invasive treatment approach that avoids …

… Barrett's oesophagus,2 a condition described by Australian-born Norman Barrett in 19573
in which the normal oesophageal … the epidemiology of Barrett's oesophagus and its rela…